| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/24/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 6.3k | $0.00 | $0 | | 06/24/2022 |
| 06/14/2022 | Cyclerion Therapeutics, Inc. | CYCN | Grant | Stock Option (Right to Buy) | 20k | $0.53 | $10.6k | | 06/14/2022 |
| 10/01/2021 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 3.6k | $0.00 | $0 | | 10/01/2021 |
| 06/25/2021 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 5.7k | $0.00 | $0 | | 06/25/2021 |
| 06/24/2021 | Cyclerion Therapeutics, Inc. | CYCN | Grant | Stock Option (Right to Buy) | 10k | $3.97 | $39.7k | | 06/24/2021 |
| 04/01/2021 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 2.9k | $0.00 | $0 | | 04/01/2021 |
| 10/01/2020 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 3.1k | $0.00 | $0 | | 10/01/2020 |
| 07/01/2020 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 2.1k | $0.00 | $0 | | 07/01/2020 |
| 06/18/2020 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 8.9k | $0.00 | $0 | | 06/15/2020 |
| 06/15/2020 | Royalty Pharma plc | RPRX | Grant | LP interests in RPI US Partners 2019, LP | 53.9k | $0.00 | $0 | By Errol Bento De Souza Revocable Trust | 06/15/2020 |
| 06/15/2020 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 35.7k | $0.00 | $0 | | 06/15/2020 |
| 06/11/2020 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 5k | $7.18 | $35.9k | | 06/11/2020 |
| 04/01/2020 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 2.9k | $0.00 | $0 | | 04/01/2020 |
| 01/02/2020 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 1.8k | $0.00 | $0 | | 01/02/2020 |
| 10/01/2019 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 2.5k | $0.00 | $0 | | 10/01/2019 |
| 07/01/2019 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 1.8k | $0.00 | $0 | | 07/01/2019 |
| 06/13/2019 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 5k | $7.46 | $37.3k | | 06/13/2019 |
| 04/01/2019 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 1.5k | $0.00 | $0 | | 04/01/2019 |
| 12/31/2018 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 1.7k | $0.00 | $0 | | 12/31/2018 |
| 06/13/2018 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 5k | $24.94 | $124.7k | | 06/13/2018 |
| 02/20/2018 | CATALYST BIOSCIENCES, INC. | CBIO | Other (disposition) | Redeemable Convertible Note | 0 | $0.00 | $0 | | 02/20/2018 |
| 02/20/2018 | CATALYST BIOSCIENCES, INC. | CBIO | Other (disposition) | Redeemable Convertible Note | 4.7k | $0.00 | $0 | | 02/20/2018 |
| 07/13/2017 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 10k | $4.40 | $44k | | 07/13/2017 |
| 06/09/2016 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 7.5k | $1.88 | $14.1k | | 06/09/2016 |
| 09/30/2015 | ALBIREO PHARMA, INC. | ALBO | Exercise | Restricted Stock Unit | 0 | $0.00 | $0 | | 09/30/2015 |
| 09/30/2015 | ALBIREO PHARMA, INC. | ALBO | Payment of Exercise | Common Stock | 43.5k | $0.44 | $19.1k | | 09/30/2015 |
| 12/19/2014 | ALBIREO PHARMA, INC. | ALBO | Grant | Stock Option (Right to Buy) | 225k | $1.39 | $312.8k | | 12/19/2014 |
| 12/11/2014 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 10k | $0.00 | $0 | | 12/11/2014 |
| 11/11/2014 | ALBIREO PHARMA, INC. | ALBO | Grant | Restricted Stock Units | 131.1k | $0.00 | $0 | | 11/11/2014 |
| 06/12/2014 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 12.5k | $4.29 | $53.6k | | 06/12/2014 |
| 03/12/2014 | ALBIREO PHARMA, INC. | ALBO | Exercise | Restricted Stock Unit | 5.6k | $0.00 | $0 | | 03/12/2014 |
| 03/12/2014 | ALBIREO PHARMA, INC. | ALBO | Payment of Exercise | Common Stock | 1.8k | $0.00 | $0 | | 03/12/2014 |
| 12/23/2013 | ALBIREO PHARMA, INC. | ALBO | Grant | Stock Option (Right to Buy) | 300k | $2.36 | $708k | | 12/23/2013 |
| 09/20/2012 | ALBIREO PHARMA, INC. | ALBO | Purchase | Common Stock | 10k | $3.34 | $33.4k | | 09/20/2013 |